Cytokinetics, Incorporated · NASDAQ:CYTK

Harrington Robert Arthur received 2,851 Cytokinetics, Incorporated shares as an award (Form 4)

Traded May 27, 2026 · Filed May 27, 2026

On May 27, 2026, Harrington Robert Arthur (Director) received 2,851 Cytokinetics, Incorporated shares as an award, leaving 21,781 shares. Filed May 27, 2026 (Form 4).

Awarded
2,851 shares
Holding after
21,781 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 27, 2026Common StockAward2,85121,781Direct

Source

View original at SEC

Related